Á-Secretase is a high-molecular-weight protein complex required for the proteolytic processing of various transmembrane proteins including the Alzheimer's diseaseassociated amyloid precursor protein and the signaling receptor Notch. One of the Á-secretase complex components is the type I transmembrane protein nicastrin. Here we review the odyssey to a cyclopic fish, which at the end allowed the functional analysis of nicalin, a novel member of the nicastrin protein family. This 60-kDa protein is part of a previously unknown membrane protein complex unrelated to Á-secretase and binds to Nomo (Nodal modulator, previously known as pM5), a novel 130-kDa transmembrane protein. Both proteins are highly conserved in metazoans and show almost identical tissue distribution in humans. Functional studies in zebrafish embryos and cultured human cells revealed that nicalin and Nomo collaborate to antagonize the Nodal/ TGFß signaling pathway. Thus, nicastrin and nicalin are both associated with protein complexes involved in cell fate decisions during early embryonic development.
The Á-secretase cleavage is the final step in the proteolytic processing of various type I transmembrane proteins that have undergone ectodomain shedding, most importantly the amyloid precursor protein (APP) and the signaling receptor Notch [1, 2] . Processing of APP leads to the generation of the amyloid-ß peptide, which is deposited in brains of Alzheimer's disease patients [3, 4] . The cleavage of Notch is required for the activation of the Notch signaling pathway, which mediates cell fate decisions at various stages during embryonic development [5, 6] . The Á-secretase cleavage is unusual, since it occurs within the hydrophobic environment of the membrane and is mediated by a high-molecular-weight protein complex consisting of presenilins, nicastrin, APH-1 and PEN-2 [7, 8] (fig. 1a) . The presenilins are polytopic transmembrane proteases which provide the active site of the Á-secretase complex [9] . The type I transmembrane protein nicastrin interacts with presenilins [10] and APH-1 [11] and is required for the assembly and stabilization of the complex. Its large extracytosolic domain contains a F200-amino acid region which is predicted to adopt a fold similar to the aminopeptidase domain found in several aminopeptidases and the transferrin receptors [12] . The integrity of the aminopeptidase domain of nicastrin is necessary for Á-secretase activity [10, 13] and the maturation of the Á-secretase complex is accompanied by a change in the structure of nicastrin [13] . Since none of the Á-secretase complex components can act by themselves, the identification of the individual functions of the components is extraordinarily difficult.
In an attempt to gain further insight into the mode of action of nicastrin, we searched for nicastrin-related proteins by scanning protein and genome databases with generalized profiles constructed from the ectodomain of the nicastrin family [14] . This search identified a novel putative transmembrane protein with the same phyletic distribution as nicastrin ( fig. 1b) . Since this protein is predicted to represent a type I transmembrane protein with the same overall architecture as nicastrin, we refer to it as nicalin (nicastrin-like protein). The sequence similarity is confined to a region of 180 residues, which roughly corresponds to the previously described aminopeptidase domain. Analysis of nicalin by blue-native polyacrylamide gel electrophoresis revealed its presence in a high-molecular-weight membrane protein complex with a size surprisingly similar to Á-secretase ( fig. 2a) . However, in nicalin immunoprecipitates, Á-secretase components were not detected demonstrating that that these complexes are completely unrelated [14] . Instead, a 130-kDa protein coprecipitated with nicalin ( fig. 2b ) which was identified by mass spectrometry as pM5, a protein of unknown function. Based on the results of our analysis in zebrafish embryos (see below), we refer to it as Nomo (Nodal modulator). The significance of the nicalin/Nomo interaction is further underscored by the following observations: (1) orthologs of both proteins can be found in invertebrates Haffner/ Haass   Fig. 2 . The nicalin/Nomo complex is involved in cell fate decisions during zebrafish embryogenesis. a Immunoblot of blue-native gels of membrane protein extracts from HEK293 cells expressing the APP Swedish mutant (Sw) and nicalin (Sw/Ncl). Nicalin immunoreactivity is seen in a high-molecular-weight complex with a size similar to Á-secretase, which is detected with an anti-presenilin 1 antibody (·-PS1). b Coomassiestained SDS gel containing proteins immunoprecipitated with ·-nicalin antibodies from Sw or Sw/Ncl cell membrane preparations. A 60-and a 130-kDa band were specifically enriched in precipitates from Sw/Ncl cells (* = immunoglobulin heavy chain). Peptide mass fingerprints generated by MALDI analysis identified these bands as nicalin and pM5, which we refer to as Nomo. c Coexpression of ncl1 and nomo in zebrafish embryos affects cell fate decisions leading to cyclopia. 36 h postfertilization morphology of a wild-type embryo (top panel) and an embryo coinjected with ncl1 and nomo capped RNAs (bottom panel). Note the prominent cyclopia of the injected embryo (arrow). and plants (fig. 1b) , (2) their tissue distribution is highly similar in humans [14] and (3) both nicalin and Nomo localize to the endoplasmic reticulum (unpubl. data).
To identify the biological function of this novel protein complex, we used the zebrafish system which has been successfully used to recapitulate the defects in somite formation associated with the inhibition of Notch signaling [15] . One Nomo (nomo) and two nicalin orthologs (ncl1, ncl2) were found in the zebrafish genome. Interfering with nomo and/or ncl1 expression levels in zebrafish embryos failed to produce phenotypes related to Notch signaling deficiencies, pointing to the distinct functions of the Á-secretase and the nicalin/Nomo complex in vivo [14] . In contrast, we found that ectopic coexpression of Nomo and Ncl1, but not of each factor alone, led to cyclopic, 'squint-eyed' embryos ( fig. 2c) . Blocking the production of Nomo with an antisense oligonucleotide resulted in the development of a massively enlarged hatching gland [14] . Both phenotypes can arise through a failure in the proper patterning of embryonic mesendodermal tissue [16, 17] , a process regulated by the TGFß factor Nodal [18] . In situ hybridization experiments indeed demonstrated that downregulation of Nomo increased the amount of anterior axial mesendoderm indicating enhanced Nodal signaling [14] . These data pointed to an antagonistic role of the nicalin/Nomo complex in the Nodal pathway and were confirmed by the finding that enhanced inhibition of Nodal signaling by the overexpression of the specific Nodal inhibitor Lefty was counteracted by blocking Nomo expression [14] . To analyze if nicalin and Nomo affect Nodal signaling directly, a luciferase reporter assay in human embryonic kidney 293T cells was established. Overexpression of nicalin or Nomo in these cells dose-dependently reduced luciferase activity derived from a TGFß-responsive promoter [14] . We, thus, propose a direct role for the nicalin/Nomo complex in the modulation of Nodal/TGFß signaling ( fig. 3) .
Taken together these recent findings suggest that proteins of the nicastrin family may have evolved to fulfill biological functions in cell fate decisions during early embryogenesis. Interestingly, the function of these proteins in Notch and Nodal signaling is associated with a high-molecular-weight protein complex.
